Several clinical studies have highlighted the potential role of remdesivir (GS-5734), as an effective SARS-CoV-2 antiviral drug. Studies examining the pharmacological and human safety profile of remdesivir will enable the preclinical and clinical evaluation of these drugs for the treatment of COVID-19.
Cambridge Bioscience offers a wide range of sizes of high purity remdesivir with short lead-times from our partners Cayman Chemical, MedChemExpress and Biovision.
Remdesivir (GS-5734), a nucleoside analogue with effective antiviral activity.
Remdesivir references
Agostini ML, et al. Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease. MBio. 2018 Mar 6;9(2). pii: e00221-18.
Please note that these products are for in vitro laboratory research use only and are not suitable for human consumption or veterinary diagnostic or therapeutic use.
Products
Note: product availability depends on country - see product detail page.
Details | Cat number & supplier | Size | Price |
Remdesivir CAY30354-5 mg · Cayman Chemical | CAY30354-5 mg Cayman Chemical |
5 mg |
£138.00
5 mg
view
|
Remdesivir CAY30354-10 mg · Cayman Chemical | CAY30354-10 mg Cayman Chemical |
10 mg |
£234.00
10 mg
view
|
Remdesivir CAY30354-50 mg · Cayman Chemical | CAY30354-50 mg Cayman Chemical |
50 mg |
£811.00
50 mg
view
|
Remdesivir CAY30354-100 mg · Cayman Chemical | CAY30354-100 mg Cayman Chemical |
100 mg |
£1311.00
100 mg
view
|